Authors:
SACHDEO RC
NARANGSACHDEO S
MONTGOMERY PA
SHUMAKER RC
PERHACH JL
LYNESS WH
ROSENBERG A
Citation: Rc. Sachdeo et al., EVALUATION OF THE POTENTIAL INTERACTION BETWEEN FELBAMATE AND ERYTHROMYCIN IN PATIENTS WITH EPILEPSY, Journal of clinical pharmacology, 38(2), 1998, pp. 184-190
Authors:
KAPETANOVIC IM
TORCHIN CD
THOMPSON CD
MILLER TA
MCNEILLY PJ
MACDONALD TL
KUPFERBERG HJ
PERHACH JL
SOFIA RD
STRONG JM
Citation: Im. Kapetanovic et al., POTENTIALLY REACTIVE CYCLIC CARBAMATE METABOLITE OF THE ANTIEPILEPTICDRUG FELBAMATE PRODUCED BY HUMAN LIVER-TISSUE IN-VITRO, Drug metabolism and disposition, 26(11), 1998, pp. 1089-1095
Authors:
GLUE P
BANFIELD CR
PERHACH JL
MATHER GG
RACHA JK
LEVY RH
Citation: P. Glue et al., PHARMACOKINETIC INTERACTIONS WITH FELBAMATE - IN-VITRO IN-VIVO CORRELATION, Clinical pharmacokinetics, 33(3), 1997, pp. 214-224
Authors:
BRONSKY EA
MELTZER EO
PERHACH JL
ROSENBERG A
LYNESS WH
Citation: Ea. Bronsky et al., CARDIAC SAFETY OF AZELASTINE FOLLOWING 8 WEEKS OF INTRANASAL ADMINISTRATION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1809-1809
Authors:
MORGANROTH J
LYNESS WH
PERHACH JL
MATHER GG
HARR JE
TRAGER WF
LEVY RH
ROSENBERG A
Citation: J. Morganroth et al., LACK OF EFFECT OF AZELASTINE AND KETOCONAZOLE COADMINISTRATION ON ELECTROCARDIOGRAPHIC PARAMETERS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(11), 1997, pp. 1065-1072
Authors:
SACHDEO R
NARANGSACHDEO SK
SHUMAKER RC
PERHACH JL
LYNESS WH
ROSENBERG A
Citation: R. Sachdeo et al., TOLERABILITY AND PHARMACOKINETICS OF MONOTHERAPY FELBAMATE DOSES OF 1,200-6,000 MG DAY IN SUBJECTS WITH EPILEPSY/, Epilepsia, 38(8), 1997, pp. 887-892
Authors:
BUSSE WW
MIDDLETON E
STORMS W
DOCKHORN RJ
CHU TJ
GROSSMAN J
WEILER JM
BRONSKY EA
MANSFIELD LE
BELL TD
HEMSWORTH GR
PERHACH JL
DELETTO TA
DAM A
Citation: Ww. Busse et al., CORTICOSTEROID-SPARING EFFECT OF AZELASTINE IN THE MANAGEMENT OF BRONCHIAL-ASTHMA, American journal of respiratory and critical care medicine, 153(1), 1996, pp. 122-127
Authors:
BANFIELD CR
ZHU GRR
JEN JF
JENSEN PK
SCHUMAKER RC
PERHACH JL
AFFRIME MB
GLUE P
Citation: Cr. Banfield et al., THE EFFECT OF AGE ON THE APPARENT CLEARANCE OF FELBAMATE - A RETROSPECTIVE ANALYSIS USING NONLINEAR MIXED-EFFECTS MODELING, Therapeutic drug monitoring, 18(1), 1996, pp. 19-29
Authors:
MORGANROTH J
PERHACH JL
LYNESS W
ROSENBERG A
Citation: J. Morganroth et al., LACK OF EFFECT OF AZELASTINE ALONE AND COADMINISTERED WITH KETACONAZOLE ON ELECTROCARDIOGRAPHIC PARAMETERS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 282-282
Authors:
RITTER FJ
LEPPIK IE
DREIFUSS FE
RAK I
SANTILLI N
HOMZIE R
DODSON WE
GLAUSER TA
SACKELLARES JC
OLSON L
GARAFOLO EA
SHIELDS WD
FRENCH J
SPERLING M
KRAMER LD
KAMIN M
ROSENBERG A
SHUMAKER R
PERHACH JL
DIX R
Citation: Fj. Ritter et al., EFFICACY OF FELBAMATE IN CHILDHOOD EPILEPTIC ENCEPHALOPATHY (LENNOX-GASTAUT SYNDROME) (REPRINTED FROM NEW-ENGLAND JOURNAL OF MED, VOL 328, PG 29, 1993), Hospital formulary, 28, 1993, pp. 29-36